Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe

A le Cesne; I Judson; D Crowther; S Rodenhuis; HJ Keizer; Q van Hoesel; JY Blay; J Frisch; M Glabbeke; C Hermans; AT van Oosterom; T Tursz; Jaap Verweij

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe

A le Cesne, I Judson, D Crowther, S Rodenhuis, HJ Keizer, Q van Hoesel, JY Blay, J Frisch, M Glabbeke, C Hermans, AT van Oosterom, T Tursz, Jaap Verweij

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

227 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2676-2684
Number of pages	9
Journal	Journal of Clinical Oncology
Volume	18
Issue number	14
Publication status	Published - 2000

Cite this

le Cesne, A., Judson, I., Crowther, D., Rodenhuis, S., Keizer, HJ., van Hoesel, Q., Blay, JY., Frisch, J., Glabbeke, M., Hermans, C., van Oosterom, AT., Tursz, T., & Verweij, J. (2000). Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe. Journal of Clinical Oncology, 18(14), 2676-2684.

le Cesne, A ; Judson, I ; Crowther, D et al. / Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe. In: Journal of Clinical Oncology. 2000 ; Vol. 18, No. 14. pp. 2676-2684.

@article{8bf3a562ac8e49b4b641c3f999eeed0f,

title = "Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe",

author = "{le Cesne}, A and I Judson and D Crowther and S Rodenhuis and HJ Keizer and {van Hoesel}, Q and JY Blay and J Frisch and M Glabbeke and C Hermans and {van Oosterom}, AT and T Tursz and Jaap Verweij",

year = "2000",

language = "Undefined/Unknown",

volume = "18",

pages = "2676--2684",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "14",

}

le Cesne, A, Judson, I, Crowther, D, Rodenhuis, S, Keizer, HJ, van Hoesel, Q, Blay, JY, Frisch, J, Glabbeke, M, Hermans, C, van Oosterom, AT, Tursz, T & Verweij, J 2000, 'Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe', Journal of Clinical Oncology, vol. 18, no. 14, pp. 2676-2684.

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe. / le Cesne, A; Judson, I; Crowther, D et al.

In: Journal of Clinical Oncology, Vol. 18, No. 14, 2000, p. 2676-2684.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe

AU - le Cesne, A

AU - Judson, I

AU - Crowther, D

AU - Rodenhuis, S

AU - Keizer, HJ

AU - van Hoesel, Q

AU - Blay, JY

AU - Frisch, J

AU - Glabbeke, M

AU - Hermans, C

AU - van Oosterom, AT

AU - Tursz, T

AU - Verweij, Jaap

PY - 2000

Y1 - 2000

M3 - Article

VL - 18

SP - 2676

EP - 2684

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 14

ER -

le Cesne A, Judson I, Crowther D, Rodenhuis S, Keizer HJ, van Hoesel Q et al. Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe. Journal of Clinical Oncology. 2000;18(14):2676-2684.